Literature DB >> 24729765

Gut bacteria in health and disease.

Eamonn M M Quigley1.   

Abstract

A new era in medical science has dawned with the realization of the critical role of the "forgotten organ," the gut micro-biota, in health and disease. Central to this beneficial interaction between the microbiota and host is the manner in which bacteria and most likely other microorganisms contained within the gut communicate with the host's immune system and participate in a variety of metabolic processes of mutual benefit to the host and the microbe. The advent of high-throughput methodologies and the elaboration of sophisticated analytic systems have facilitated the detailed description of the composition of the microbial constituents of the human gut, as never before, and are now enabling comparisons to be made between health and various disease states. Although the latter approach is still in its infancy, some important insights have already been gained about how the microbiota might influence a number of disease processes both within and distant from the gut. These discoveries also lay the groundwork for the development of therapeutic strategies that might modify the microbiota (eg, through the use of probiot-ics). Although this area holds much promise, more high-quality trials of probiotics, prebiotics, and other microbiota-modifying approaches in digestive disorders are needed, as well as laboratory investigations of their mechanisms of action.

Entities:  

Keywords:  Gut flora; gut bacteria; microbial metabolism; microbiota; mucosal immunology; probiotic

Year:  2013        PMID: 24729765      PMCID: PMC3983973     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


  118 in total

1.  Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination.

Authors:  A S Neish; A T Gewirtz; H Zeng; A N Young; M E Hobert; V Karmali; A S Rao; J L Madara
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

Review 2.  Role of commensal gut bacteria in inflammatory bowel diseases.

Authors:  Gunnar Loh; Michael Blaut
Journal:  Gut Microbes       Date:  2012-10-11

3.  Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice.

Authors:  Marc-Emmanuel Dumas; Richard H Barton; Ayo Toye; Olivier Cloarec; Christine Blancher; Alice Rothwell; Jane Fearnside; Roger Tatoud; Véronique Blanc; John C Lindon; Steve C Mitchell; Elaine Holmes; Mark I McCarthy; James Scott; Dominique Gauguier; Jeremy K Nicholson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-08       Impact factor: 11.205

Review 4.  Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date.

Authors:  E M M Quigley; B Flourie
Journal:  Neurogastroenterol Motil       Date:  2007-03       Impact factor: 3.598

5.  Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors.

Authors:  Christel Rousseaux; Xavier Thuru; Agathe Gelot; Nicolas Barnich; Christel Neut; Laurent Dubuquoy; Caroline Dubuquoy; Emilie Merour; Karen Geboes; Mathias Chamaillard; Arthur Ouwehand; Greg Leyer; Didier Carcano; Jean-Frédéric Colombel; Denis Ardid; Pierre Desreumaux
Journal:  Nat Med       Date:  2006-12-10       Impact factor: 53.440

6.  The microbiome-gut-brain axis: from bowel to behavior.

Authors:  J F Cryan; S M O'Mahony
Journal:  Neurogastroenterol Motil       Date:  2011-03       Impact factor: 3.598

Review 7.  Bacteria: a new player in gastrointestinal motility disorders--infections, bacterial overgrowth, and probiotics.

Authors:  Eamonn M M Quigley
Journal:  Gastroenterol Clin North Am       Date:  2007-09       Impact factor: 3.806

8.  Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome.

Authors:  J Zeng; Y-Q Li; X-L Zuo; Y-B Zhen; J Yang; C-H Liu
Journal:  Aliment Pharmacol Ther       Date:  2008-07-30       Impact factor: 8.171

Review 9.  Gut motor function: immunological control in enteric infection and inflammation.

Authors:  W I Khan; S M Collins
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

10.  Treatment of ulcerative colitis using fecal bacteriotherapy.

Authors:  Thomas J Borody; Eloise F Warren; Sharyn Leis; Rosa Surace; Ori Ashman
Journal:  J Clin Gastroenterol       Date:  2003-07       Impact factor: 3.062

View more
  96 in total

Review 1.  Gut microbiota: a key player in health and disease. A review focused on obesity.

Authors:  M J Villanueva-Millán; P Pérez-Matute; J A Oteo
Journal:  J Physiol Biochem       Date:  2015-03-08       Impact factor: 4.158

Review 2.  Changes in Gut Microbiota and Hormones After Bariatric Surgery: a Bench-to-Bedside Review.

Authors:  Mohsen Tabasi; Fatemeh Ashrafian; Jamil Kheirvari Khezerloo; Sahar Eshghjoo; Ava Behrouzi; Seyed Alireza Javadinia; Farid Poursadegh; Sana Eybpoosh; Sara Ahmadi; Amin Radmanesh; Ahmadreza Soroush; Seyed Davar Siadat
Journal:  Obes Surg       Date:  2019-05       Impact factor: 4.129

Review 3.  Microbiota in cancer development and treatment.

Authors:  Muhammad Hassan Raza; Kamni Gul; Abida Arshad; Naveeda Riaz; Usman Waheed; Abdul Rauf; Fahad Aldakheel; Shatha Alduraywish; Maqbool Ur Rehman; Muhammad Abdullah; Muhammad Arshad
Journal:  J Cancer Res Clin Oncol       Date:  2018-12-12       Impact factor: 4.553

Review 4.  Reevaluating the hype: four bacterial metabolites under scrutiny.

Authors:  E E Fröhlich; R Mayerhofer; P Holzer
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2015-03-26

5.  Cumulative Antibiotic Use Significantly Decreases Efficacy of Checkpoint Inhibitors in Patients with Advanced Cancer.

Authors:  Nadina Tinsley; Cong Zhou; Grace Tan; Samuel Rack; Paul Lorigan; Fiona Blackhall; Matthew Krebs; Louise Carter; Fiona Thistlethwaite; Donna Graham; Natalie Cook
Journal:  Oncologist       Date:  2019-07-10

Review 6.  Progress in Our Understanding of the Gut Microbiome: Implications for the Clinician.

Authors:  Sara Iqbal; Eamonn M M Quigley
Journal:  Curr Gastroenterol Rep       Date:  2016-09

7.  Probiotic pre-administration reduces mortality in a mouse model of cecal ligation and puncture-induced sepsis.

Authors:  Lufang Chen; Keying Xu; Qifeng Gui; Yue Chen; Deying Chen; Yunmei Yang
Journal:  Exp Ther Med       Date:  2016-07-20       Impact factor: 2.447

8.  Effect of probiotics supplementation on glucose and oxidative stress in type 2 diabetes mellitus: a meta-analysis of randomized trials.

Authors:  Edris Ardeshirlarijani; Ozra Tabatabaei-Malazy; Shahrzad Mohseni; Mostafa Qorbani; Bagher Larijani; Reza Baradar Jalili
Journal:  Daru       Date:  2019-11-05       Impact factor: 3.117

9.  Fecal Fatty Acid Profiling as a Potential New Screening Biomarker in Patients with Colorectal Cancer.

Authors:  Eun Mi Song; Jeong-Sik Byeon; Sun Mi Lee; Hyun Ju Yoo; Su Jung Kim; Sun-Ho Lee; Kiju Chang; Sung Wook Hwang; Dong-Hoon Yang; Jin-Yong Jeong
Journal:  Dig Dis Sci       Date:  2018-03-07       Impact factor: 3.199

Review 10.  The role of topical probiotics on wound healing: A review of animal and human studies.

Authors:  Rebecca Knackstedt; Thomas Knackstedt; James Gatherwright
Journal:  Int Wound J       Date:  2020-08-31       Impact factor: 3.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.